Company: PBH
Filing Date: 2025-02-06
Form Type: 10-Q
Source: 0001295947-25-000009
Chunk: 15

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-02-06
Form: 10-Q
Item: Item 2
Chunk 15
---
2023.  The average cost of borrowing decreased to 4.6% for the three months ended December 31, 2024 from 5.4% for the three months ended December 31, 2023.

Income Taxes

The provision for income taxes during the three months ended December 31, 2024 was $19.1 million versus $16.5 million during the three months ended December 31, 2023.  The effective tax rate during the three months ended December 31, 2024 was 23.9% versus 23.8% during the three months ended December 31, 2023. 

-26-

Results of Operations 

Nine Months Ended December 31, 2024 compared to the Nine Months Ended December 31, 2023

Total Segment Revenues

The following table represents total revenue by segment, including product groups, for the nine months ended December 31, 2024 and 2023.

Nine Months Ended December 31,Increase (Decrease)(In thousands)2024%2023%Amount%North American OTC HealthcareAnalgesics$83,472 9.9 $85,838 10.1 $(2,366)(2.8)Cough & Cold60,999 7.3 73,703 8.7 (12,704)(17.2)Women's Health158,490 18.8 163,031 19.3 (4,541)(2.8)Gastrointestinal128,719 15.3 122,303 14.4 6,416 5.2 Eye & Ear Care118,354 14.1 117,719 13.9 635 0.5 Dermatologicals93,789 11.1 94,299 11.1 (510)(0.5)Oral Care58,241 6.9 61,400 7.2 (3,159)(5.1)Other OTC8,997 1.1 8,838 1.0 159 1.8 Total North American OTC Healthcare711,061 84.5 727,131 85.7 (16,070)(2.2)International OTC HealthcareAnalgesics$4,025 0.5 $3,814 0.4 211 5.5